We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

108 hedge funds and large institutions have $148M invested in Surgalign Holdings, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 35 increasing their positions, 34 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $141M → $148M (+$7.05M)

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

3% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

2% less funds holding

Funds holding: 110108 (-2)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $8K

Holders
108
Holders Change
-2
Holders Change %
-1.82%
% of All Funds
2.7%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
12
Increased
35
Reduced
34
Closed
11
Calls
Puts
$8K
Net Calls
-$8K
Net Calls Change
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
NFA
51
Nationwide Fund Advisors
Ohio
$274K -$12K -131 -4%
UBS Group
52
UBS Group
Switzerland
$269K +$17K +186 +7%
JP Morgan Chase
53
JP Morgan Chase
New York
$247K +$233K +2,537 New
State Board of Administration of Florida Retirement System
54
State Board of Administration of Florida Retirement System
Florida
$236K
BCM
55
Bridgeway Capital Management
Texas
$228K +$114K +1,246 +115%
RhumbLine Advisers
56
RhumbLine Advisers
Massachusetts
$225K +$8.62K +94 +4%
Invesco
57
Invesco
Georgia
$221K -$1.19K -13 -0.6%
TA
58
Teton Advisors
New York
$215K
PCM
59
Prelude Capital Management
New York
$207K +$48K +524 +33%
BG
60
BlackRock Group
United Kingdom
$200K
AllianceBernstein
61
AllianceBernstein
Tennessee
$192K
Axa
62
Axa
France
$188K
Citigroup
63
Citigroup
New York
$188K +$161K +1,753 +1,002%
Goldman Sachs
64
Goldman Sachs
New York
$183K +$57.1K +623 +49%
New York State Common Retirement Fund
65
New York State Common Retirement Fund
New York
$170K
VKH
66
Virtu KCG Holdings
New York
$158K +$72.5K +791 +95%
Millennium Management
67
Millennium Management
New York
$146K -$311K -3,389 -69%
Manulife (Manufacturers Life Insurance)
68
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$143K +$2.75K +30 +2%
SRC
69
Shufro Rose & Co
New York
$125K
Bank of America
70
Bank of America
North Carolina
$121K +$10.2K +111 +10%
Federated Hermes
71
Federated Hermes
Pennsylvania
$120K
VOYA Investment Management
72
VOYA Investment Management
Georgia
$117K
Ameriprise
73
Ameriprise
Minnesota
$116K +$16.2K +177 +18%
Deutsche Bank
74
Deutsche Bank
Germany
$111K +$76.7K +837 +264%
AIG
75
American International Group
New York
$107K -$275 -3 -0.3%

SRGA Hedge Fund Activity: Q4 2016 in Review

108 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q4 2016, worth a combined $148M — up 5% from $141M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new SRGA positions and 11 closed out — a net gain of 1 holder — while 35 added to existing stakes and 34 trimmed.

The largest buyer was Foundry Partners, opening a new position worth an estimated $3.02M. The largest seller was BlackRock Institutional Trust, cutting an estimated $2.05M.

  • 108 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q4 2016, down from 110 in Q3 2016.
  • Funds reported $148M of Surgalign Holdings, Inc. Common Stock stock for Q4 2016, up 5% quarter-over-quarter.
  • 12 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q4 2016 and 11 closed out, a net change of +1 holder.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q4 2016 was Foundry Partners, an estimated $3.02M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q4 2016 was BlackRock Institutional Trust, an estimated $2.05M sold.

Based on aggregated 13F filings for Q4 2016.